MTOR and endometrial cancer: In summary, our data show that thioridazine can inhibit the PI3K/Akt/mTOR/p70S6K signaling pathway and exert cytotoxic effect on cervical and endometrial cancer cells by inducing cell cycle arrest and apoptosis.